Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 70518-3636 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Pregabalin is a medication available in the form of capsules with a strength of 50mg. A quantity of 90 capsules is provided and it's a prescription-only drug. The medication is sourced from Ascend Labs, LLC located in Montvale, NJ 07645. The lot number is not available. Patients are advised to store the medication at a temperature between 20-25°C and keep it away from children. Directions for use are present in the package insert. The drug is repackaged by RemedyRepack Inc. located in Indiana, PA 15701.*

pregabalin-equation - pregabalin equation

pregabalin-equation - pregabalin equation

This appears to be a medical equation for estimating creatinine clearance (CLCr) based on age, weight, and serum creatinine level (measured in mg/dL). The equation involves multiplying 140 by the patient's weight and dividing by their serum creatinine level, adjusted for age. The note about a CLCr value greater than 0.85 for female patients suggests this equation may be used in the context of renal function assessment.*

pregabalin-Figure-6 - pregabalin figure 6

pregabalin-Figure-6 - pregabalin figure 6

This appears to be a table containing data from Study E1 and Study E3, with different treatment groups and percentages. The study involves testing the effectiveness of various dosages of a drug (ranging from 50mg/day to 600mg/day) compared to a placebo. The table seems to show that some dosages of the drug were statistically significant compared to the placebo, but without more context it is difficult to draw conclusions about the study's findings.*

pregabalin-Figure-7 - pregabalin figure 7

pregabalin-Figure-7 - pregabalin figure 7

Study DPN 1 - pregabalin image 1

Study DPN 1 - pregabalin image 1

Study SCI 1 - pregabalin image 10

Study SCI 1 - pregabalin image 10

Pain Intensity-study SCI 2 - pregabalin image 11

Pain Intensity-study SCI 2 - pregabalin image 11

Study DPN 2 - pregabalin image 2

Study DPN 2 - pregabalin image 2

Study PHN 1 - pregabalin image 3

Study PHN 1 - pregabalin image 3

Study PHN 2 - pregabalin image 4

Study PHN 2 - pregabalin image 4

The text provides information on the percentage of patients who improved in pain from baseline after being prescribed Pregabalin in either 200mg or 100mg doses three times a day, compared to a placebo. The exact percentage is not available due to errors in .*

Study PHN 3 - pregabalin image 5

Study PHN 3 - pregabalin image 5

Fibromyalgia Study F1 - pregabalin image 8

Fibromyalgia Study F1 - pregabalin image 8

The text is a chart showing the percentage of patients who improved with different doses of Pregabalin for pain relief. It also includes the percentage of improvement in pain from the baseline for each dose.*

Fibromyalgia Study F2 - pregabalin image 9

Fibromyalgia Study F2 - pregabalin image 9

Pregabalin structure - pregabalin srtuc 1

Pregabalin structure - pregabalin srtuc 1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.